A recent meta-analysis [ 7 ] confirmed a highly significant reduction in relapse for MBCT compared to treatment as usual (TAU) for people with three or more episodes of depression, with effects at least equal to maintenance antidepressant medication.
← all excerpts
The DARE study of relapse prevention in depression: design for a phase 1/2 translational randomised controlled trial involving mindfulness-based cognitive therapy and supported self monitoring.
1
—
—